Martin Shkreli, the controversial pharmaceutical CEO and former hedge fund manager, announced that he would reduce the price of the drug Daraprim to “a point that is more affordable.” Shkreli has been the subject of unrelenting criticism since he implemented a 5000% increase in the price of the drug — from $13.50 per pill to $750 — which is used …